Identification and functional significance of polymorphisms in the μ-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice

Neuroscience Research

Volumn 55, Issue 3, 2006, Pages 244-254

  Doyle, Glenn A ^a   Sheng, X Rebecca ^a   Schwebel, Candice L ^a   Ferraro, Thomas N ^a   Berrettini, Wade H ^a   Buono, Russell J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Morphine; Mouse opioid receptor; Oprm promoter; Strain difference

Indexed keywords

GENOMIC DNA; LUCIFERASE; MORPHINE; MU OPIATE RECEPTOR; NUCLEOTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DNA POLYMORPHISM; DRUG ACTIVITY; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE VECTOR; GENETIC STRAIN; GENETIC VARIABILITY; INVERSE POLYMERASE CHAIN REACTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; NEURONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, OPIOID, MU; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY;

EID: 33646790524     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.03.005     Document Type: Article

References (55)

1. Abbadie C., and Pasternak G.W. Differential in vivo internalization of MOR-1 and MOR-1C by morphine. Neuroreport 12 14 (2001) 3069-3072
2. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 3 (1990) 403-410
3. Belknap J.K. Physical dependence induced by the voluntary consumption of morphine in inbred mice. Pharmacol. Biochem. Behav. 35 2 (1990) 311-315
4. Belknap J.K., Crabbe J.C., Riggan J., and O'Toole L.A. Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacol. (Berl.) 112 2-3 (1993) 352-358
5. Belknap J.K., Mogil J.S., Helms M.L., Richards S.P., O'Toole L.A., Bergeson S.E., and Buck K.J. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci. 57 10 (1995) PL117-PL224
6. Bergeson S.E., Helms M.L., O'Toole L.A., Jarvis M.W., Hain H.S., Mogil J.S., and Belknap J.K. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm. Genome 12 7 (2001) 546-553
7. Berrettini W.H., Ferraro T.N., Alexander R.C., Buchberg A.M., and Vogel W.H. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat. Genet. 7 1 (1994) 54-58
8. Brodsky M., Elliott K., Hynansky A., and Inturrisi C.E. CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone. Brain Res. Bull. 38 2 (1995) 135-141
9. Buzas B., Rosenberger J., and Cox B.M. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 7 9 (1996) 1505-1508
10. Castelli M.P., Melis M., Mameli M., Fadda P., Diaz G., and Gessa G.L. Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res. Mol. Brain Res. 45 1 (1997) 149-153
11. Choe C., Im H.J., Ko J.L., and Loh H.H. Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter. J. Biol. Chem. 273 52 (1998) 34926-34932
12. Evans C.J. Agonist selective mu-opioid receptor trafficking in rat central nervous system. Mol. Psychiatry 5 2 (2000) 121
13. Giros B., Pohl M., Rochelle J.M., and Seldin M.F. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci. 56 18 (1995) PL369-PL375
14. Hall F.S., Li X.F., Goeb M., Roff S., Hoggatt H., Sora I., and Uhl G.R. Congenic C57BL/6 mu opiate receptor (MOR) knockout mice: baseline and opiate effects. Genes Brain Behav. 2 2 (2003) 114-122
15. Herr W., and Cleary M.A. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9 14 (1995) 1679-1693
16. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Monteillet-Agius G., Stewart P.L., Evans C.J., and von Zastrow M. Mu-opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 53 3 (1998) 377-384
17. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., and von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271 32 (1996) 19021-19024
18. Ko J.L., Liu H.C., and Loh H.H. Role of an AP-2-like element in transcriptional regulation of mouse micro-opioid receptor gene. Brain Res. Mol. Brain Res. 112 1-2 (2003) 153-162
19. Ko J.L., Minnerath S.R., and Loh H.H. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophys. Res. Commun. 234 2 (1997) 351-357
20. Koch T., Schulz S., Pfeiffer M., Klutzny M., Schroder H., Kahl E., and Hollt V. C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization. J. Biol. Chem. 276 33 (2001) 31408-31414 Epub May 18
21. Koch T., Schulz S., Schröder H., Wolf R., Raulf E., and Höllt V. Carboxy-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 22 (1998) 13652-13657
22. Kozak C.A., Filie J., Adamson M.C., Chen Y., and Yu L. Murine chromosomal location of the μ and κ opioid receptor genes. Genomics 21 3 (1994) 659-661
23. Latchman D.S. POU family transcription factors in the nervous system. J. Cell Physiol. 179 2 (1999) 126-133
24. Lee P.W., and Lee Y.M. Transcriptional regulation of mu opioid receptor gene by cAMP pathway. Mol. Pharmacol. 64 6 (2003) 1410-1418
25. Li P., He X., Gerraro M.R., Mok M., Aggarwal A., and Rosenfeld M.G. Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. Genes Dev. 7 12B (1993) 2483-2496
26. Liang Y., and Carr L.G. Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene. J. Neurochem. 67 4 (1996) 1352-1359
27. Liang Y., and Carr L.G. Transcription of the mouse mu-opioid receptor gene is regulated by two promoters. Brain Res. 769 2 (1997) 372-374
28. Liang Y., Mestek A., Yu L., and Carr L.G. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679 1 (1995) 82-88
29. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., and Wei L.N. Mu opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54 2 (1998) 321-326
30. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 6603 (1996) 819-823
31. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. U.S.A. 91 19 (1994) 9081-9085
32. Pan Y.X. Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants. Gene 295 1 (2002) 97-108
33. Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., Rossi G., and Pasternak G.W. Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol. Pharmacol. 56 2 (1999) 396-403
34. Pan Y.X., Xu J., Bolan E., Chang A., Mahurter L., Rossi G., and Pasternak G.W. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. FEBS Lett. 466 2-3 (2000) 337-340
35. Pan Y.X., Xu J., Bolan E., Moskowitz H.S., Xu M., and Pasternak G.W. Identification of four novel MOR-1B splice variants of the mouse mu opioid receptor gene: functional consequences of C-terminus splicing. Mol. Pharmacol. 68 3 (2005) 866-875 Epub June 6, 2005
36. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U.S.A. 98 24 (2001) 14084-14089
37. Pasternak G.W. The pharmacology of mu analgesics: from patients to genes. Neuroscientist 7 3 (2001) 220-231
38. Petruzzi R., Ferraro T.N., Kurschner V.C., Golden G.T., and Berrettini W.H. The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice. Life Sci. 61 20 (1997) 2057-2064
39. Phillips K., and Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302 5 (2000) 1023-1039
40. Ronnekleiv O.K., Bosch M.A., Cunningham M.J., Wagner E.J., Grandy D.K., and Kelly M.J. Downregulation of mu-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neurosci. Lett. 216 2 (1996) 129-132
41. Sarton E., Teppema L., Nieuwenhuijs D., Matthes H.W., Kieffer B., and Dahan A. Opioid effect on breathing frequency and thermogenesis in mice lacking exon 2 of the mu-opioid receptor gene. Adv. Exp. Med. Biol. 499 (2001) 399-404
42. Schreiber E., Harshman K., Kemler I., Malipiero U., Schaffner W., and Fontana A. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 18 18 (1990) 5495-5503
43. Sora I., Li X.F., Funada M., Kinsey S., and Uhl G.R. Visceral chemical nociception in mice lacking mu-opioid receptors: effects of morphine, SNC80 and U-50,488. Eur. J. Pharmacol. 366 2-3 (1999) R3-R5
44. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., and Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U.S.A. 94 4 (1997) 1544-1549
45. 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J. Pharmacol. Exp. Ther. 270 3 (1994) 1246-1255
46. Sternini C., Spann M., Anton B., Keith Jr. D.E., Bunnet N.W., von Zastrow M., Evans C., and Brecha N.C. Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U.S.A. 93 17 (1996) 9241-9246
47. Suzuki S., Miyagi T., Chuang T.K., Chuang L.F., Doi R.H., and Chuang R.Y. Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem. Biophys. Res. Commun. 279 2 (2000) 621-628
48. Tian M., Broxmeyer H.E., Fan Y., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R.M., Steinmetz R., Engle S.J., Mestek A., Pollock J.D., Lehman M.N., Jansen H.T., Ying M., Stambrook P.J., Tischfield J.A., and Yu L. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J. Exp. Med. 185 8 (1997) 1517-1522
49. Uhl G.R., Sora I., and Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl. Acad. Sci. U.S.A. 96 14 (1999) 7752-7755
50. Vazquez-Martinez R., Leclerc G.M., Wierman M.E., and Boockfor F.R. Episodic activation of the rat GnRH promoter: role of the homeoprotein oct-1. Mol. Endocrinol. 16 9 (2002) 2093-2100
51. Wood P.L., and Iyengar S. Central actions of opiates and opioid peptides: in vivo evidence for opioid receptor multiplicity. In: Pasternak G.W. (Ed). The Opiate Receptors (1988), Humana Press Inc., Clifton, NJ 307-356
52. Xu Y., and Carr L.G. Binding of Sp1/Sp3 to the proximal promoter of the hMOR gene is enhanced by DAMGO. Gene 274 1-2 (2001) 119-128
53. Yoo J.H., Yang E.M., Lee S.Y., Loh H.H., Ho I.K., and Jang C.G. Differential effects of morphine and cocaine on locomotor activity and sensitization in mu-opioid receptor knockout mice. Neurosci. Lett. 344 1 (2003) 37-40
54. Yu X., Mao X., Blake A.D., Li W.X., and Chang S.L. Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 306 2 (2003) 447-454 Epub May 16
55. Zaki P.A., Keith Jr. D.E., Brine G.A., Carroll F.I., and Evans C.J. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?. J. Pharmacol. Exp. Ther. 292 3 (2000) 1127-1134